19 results
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_/

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Pnuemonia Management Algorithm ... - IDSA 2019 Guidelines ... #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Pnuemonia Management Algorithm ... - IDSA 2019 Guidelines ... #IDSA2019 #Guidelines ... #Inpatient #HAP ... #HCAP #Treatment
Antiarrhythmics - Vaughan Williams Classification
Class I (Ia, Ib, Ic) - Na+ Channel Blockade
 • Slows depolarization
Vaughan Williams Classification ... depolarization in fast AP ... rate and prolongs PR ... rate and prolongs PR ... VaughanWilliams #Classification
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
Vaughan Williams Classification ... Action, ↑ EFR & AP ... depolarization • ↑ PR ... velocity) - ↑ PR ... #Pharmacology #Classification
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... functional ID) Guidelines ... #cardiology #treatment ... #guidelines
Traditionally, congestive heart failure has been classified according to severity of symptoms, first formulated by the
heart failure has ... sometimes advanced treatment ... III and class IV ... HeartFailure #Staging #Classification ... #Stages #Classes
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Vaughan Williams Classification ... Action, ↑ EFR & AP ... depolarization • ↑ PR ... velocity) - ↑ PR ... #Pharmacology #Classification
The management of hypoxia in a patient undergoing a procedure has a variety of etiologies, but
undergoing a procedure has ... have a general treatment ... guidline. ... #diagnosis #algorithm ... #management #treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
exacerbations Drug Class ... Inhibitor GOLD 2019 Guideline ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... exacerbations. 2019 GOLD guidelines
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Framework - MAP ... Blood Loss, GI Losses ... Dehydration Shock Treatment ... #criticalcare #algorithm ... #treatment #management